Status:
UNKNOWN
AI Guidance for Biopsy in Suspected Cholangiocarcinoma
Lead Sponsor:
Instituto Ecuatoriano de Enfermedades Digestivas
Conditions:
Neoplasms
Non-Neoplastic
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Digital single-operator cholangioscopy (DSOC) has emerged as a medical advance with an important role in the evaluation of indeterminate biliary lesions. This technique has demonstrated higher sensiti...
Detailed Description
The diagnosis and management of biliary malignancy currently represents a medical challenge. To date, DSOC has demonstrated high sensitivity in the detection of malignant biliary lesions, nevertheless...
Eligibility Criteria
Inclusion
- Patients referred to our center with an indication of DSOC due to suspicion of CBD tumor or indeterminate CBD stenosis.
- Patients who authorized for DSOC-guided biopsy.
Exclusion
- Any clinical condition which makes DSOC inviable.
- Patients with more than one DSOC.
- Lost on a six-month follow-up after DSOC.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05374122
Start Date
May 1 2022
End Date
May 1 2024
Last Update
March 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carlos Robles-Medranda
Guayaquil, Guayas, Ecuador, 090505